Chinese manufactured injectable drug boosting Kenya's war against malaria

NAIROBI, Oct. 13 (Xinhua) -- Kenya's battle against malaria has gained new momentum through the widespread deployment of an injectable drug manufactured by the Chinese pharmaceutical company, Fosun Pharma, Kenyan officials said Thursday, during a forum in the western Kenyan city of Kisumu.

Kibor Keitany, the head of the National Malaria Control Program in the Ministry of Health, said that Fosun Pharma's second-generation artesunate for injection, marketed under the Argesun brand name, has proven effective in treating severe malaria cases.